We used a cumulative logistic random-effects model to test for an overall trend and additionally tested if the smear results were significantly different between the different time points with the Wilcoxon signed-rank test (for paired samples).
← all excerpts
High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.
1
—
—